Physical Activity, Hormone Replacement Therapy, and the Presence of Coronary Calcium in Midlife Women

Women and Health

Volumn 52, Issue 5, 2012, Pages 423-436

  Weinberg, Nicole ^a   Young, Amelia ^a   Hunter, Carol J ^a   Agrawal, Nisha ^a   Mao, Songshou ^a   Budoff, Matthew J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

atherosclerosis; coronary calcium; hormone therapy; perimenopause; women

Indexed keywords

CALCIUM;

AGED; ARTERIOSCLEROSIS; ARTICLE; CALCINOSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY BLOOD VESSEL; CROSS-SECTIONAL STUDY; DIET; ESTROGEN THERAPY; EXERCISE; FEMALE; HOSPITALIZATION; HUMAN; LIFESTYLE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; POSTMENOPAUSE; PREVALENCE; RADIOGRAPHY; RISK; RISK FACTOR; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; CALCINOSIS; CALCIUM; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; DIET; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; HUMANS; LIFE STYLE; LOGISTIC MODELS; MIDDLE AGED; MOTOR ACTIVITY; ODDS RATIO; POSTMENOPAUSE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863595084     PISSN: 03630242     EISSN: 15410331     Source Type: Journal    
DOI: 10.1080/03630242.2012.682705     Document Type: Article

References (35)

1. Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M. and Detrano, R. 1990. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol, 15: 827-32.
2. Akhrass, F., Evans, A. R., Wang, Y., Rich, S., Kannan, C. R., Fogefeld, L. and Mazzone, T. 2003. Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. J Clin Endo & Metab, 88(12): 5611-4.
3. Appt, S. E., Clarkson, T. B., Lees, C. J. and Anthony, M. S. 2006. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys. Maturitas, 55(2): 187-94.
4. Baecke, J. A., Burema, J. and Frijters, J. E. 1982. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr, 36: 936-42.
5. Barrett-Connor, E. and Laughlin, G. A. 2005. Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: The Rancho Bernardo study. Menopause, 12(1): 40-8.
6. Budoff, M. J., Achenbach, S., Blumenthal, R. S., Carr, J. J., Goldin, J. G.Greenland, P. 2006. Assessment of coronary artery disease by cardiac computed tomography: A scientific statementf rom the American Heart Association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology. Circulation, 114(16): 1761-91.
7. Budoff, M. J., Chen, G. P. W., Hunter, C. J., Takasu, J., Agrawal, N., Sorochinsky, B. and Mao, S. S. 2005. Effects of hormone replacement on progression of coronary calcium as measured by electron beam tomography. J Women's Health (Larchmt), 14(5): 410-7.
8. Budoff, M. J., Nasir, K., McClelland, R. L., Detrano, R., Wong, N.Blumenthal, R. S. 2009. Coronary calcium predicts events better with absolute calcium scores than age-gender-race percentiles-The Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol, 53: 345-52.
9. Budoff, M. J., Raggi, P., Berman, D., Arad, Y., Guerci, A. D., Callister, T. Q. and Diamond, G. A. 2002. Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation, 105(15): 1791-6.
10. Desai, M. Y., Nasir, K., Rumberger, J. A., Braunstein, J. B., Post, W. S., Budoff, M. J. and Blumenthal, R. S. 2004. Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors. Am J Cardiol, 94(6): 729-32.
11. Greenland, P., LaBree, L., Azen, S. P., Doherty, T. M. and Detrano, R. C. 2004. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA-J Am Med Assoc, 291: 210-5.
12. Haberl, R., Becker, A., Leber, A., Knez, A., Becker, C.Lang, C. 2001. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: Results of 1,764 patients. J Am Coll Cardiol, 37: 451
13. Hagberg, J. M., McCole, S. D., Ferrel, R. E., Smuda, J. M., Rodgers, K. S., Wilund, K. R. and Moore, G. E. 2003. Physical activity, hormone replacement therapy and plasma lipoprotein-lipid levels in postmenopausal women. Int J Sports Med, 24(1): 22-9.
14. Harman, S. M., Brinton, E. A., Cedars, M., Lobo, R., Manson, J. E.Merria, G. R. 2005. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric, 8(1): 3-12.
15. Hodis, H. N. and Mack, W. J. 2008. Postmenopausal hormone therapy and cardiovascular disease in perspective. Clin Obstet Gynecol, 51: 564-80.
16. Hsia, J., Langer, R. D., Manson, J. E., Kuller, L., Johnson, K. C.Hendrix, S. L. 2006. Conjugated equine estrogens and coronary heart disease. The women's health initiative. Arch Intern Med, 166: 357-65.
17. Hsia, J., Otvos, J. D., Rossouw, J. E., Wu, L., Wassertheil-Smoller, S.Hendrix, S. L. 2008. Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials. Arterioscler Thromb Vasc Biol, 28: 1666-71.
18. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B. and Vittinghoff, E. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) research group. JAMA-J Am Med Assoc, 280: 605-13.
19. Hunter, C. J., Kim, H. T., Sorochinsky, B. and Budoff, M. J. 2001. Physical activity, hormone replacement therapy and atherosclerosis in midlife women. Circulation, 104: 535-6.
20. Jayo, M. J., Register, T. C. and Carlson, C. S. 1998. Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys. Bone, 23(4): 361-6.
21. Kleinbaum, D. G. 1994. Logistic regression: A self-learning text, New York: Springer-Verlag.
22. Kuller, L. H., Matthews, K. A., Sutton-Tyrrell, K., Edmundowicz, D. and Bunker, C. H. 1999. Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: The Healthy Women Study. Arterioscler Thromb Vasc Biol, 19: 2189-98.
23. Lemay, A. 2002. The relevance of the women's health initiative results on combined hormone replacement therapy in clinical practice. J Obstet Gynecol Can, 24(9): 711-5.
24. Manson, J. E., Allison, M. A., Rossouw, J. E., Carr, J. J., Langer, R. D.Hsia, J. 2007. Estrogen therapy and coronary-artery calcification. The Women's Health Initiative. NEJM, 365(25): 2591-602.
25. Mosca, L., Appel, L. J., Benjamin, E. J., Berra, K., Chandra-Strobos, N.Fabunmi, R. P. 2004. Evidence-based guidelines for cardiovascular disease prevention in women: Expert panel/writing group. Circulation, 109: 672-93.
26. National Cholesterol Education Program (NCEP). 1993. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults, Bethesda, MD: U. S. Department of Health and Human Services (Publication No. HIH 93-3095).
27. North American Menopause Society. 2010. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause, 17(2): 242-55.
28. PEPI Trial Writing Group. 1995. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA-J Am Med Assoc, 273: 199-208.
29. Pettee, K. K., Kriska, A. M., Johnson, B. D., Conroy, M. B., Mackey, R. H., Orchard, T. J. and Kuller, L. H. 2007. The relationship between physical activity and lipoprotein subclasses in postmenopausal women: The influence of hormone therapy. Menopause, 14(1): 115-22.
30. Ratti, C., Grassi, L., Chiurlia, E., Bursi, F., Bompani, B., Ferramosca, E. and Modena, M. G. 2007. Coronary calcifications in a subgroup of post-menopausal women with metabolic syndrome. G Ital Cardiol (Rome), 8(9): 574-9.
31. Rosner, B. 1995. Fundamentals of biostatistics, 4th, Belmont, CA: Duxbury Press.
32. Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C.Stefanick, M. L. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA-J Am Med Assoc, 288(3): 321-33.
33. Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D.Barnabei, V. M. 2007. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA-J Am Med Soc, 297: 1465-77.
34. Schisterman, E. F., Gallagher, A. M., BaireyMerz, C. N., Whitcomb, B. W., Faraggi, D., Moysich, K. B. and Lewin, H. 2002. The association of hormone replacement therapy and coronary calcium as determined by electron beam tomography. J Women Health Gen-B, 11(7): 631-8.
35. Sourander, L., Rajala, T., Räihä, I. R, Mäkinen, J. M, Erkkola, R. and Helenius, H. 1998. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on estrogen replacement therapy. Lancet, 352: 1965-9.